- Home
- Advocacy
- Latest News and Practice Data
- In Case You Missed It: FDA Webinar - Labeling Requirements for In Vitro Diagnostic Products (IVD), Including LDTs
On September 24, the Food and Drug Administration (FDA) held a webinar on how to comply with labeling requirements for in vitro diagnostic products (IVD), including laboratory-developed tests (LDTs). The focus of this webinar was on labeling requirements for test systems, under FDA regulations and did not cover labeling requirements for other types of IVDs such as collection devices and general purpose reagents. View the printable slides. Watch the webinar on-demand.
All previous FDA LDT webinars can be viewed here.